Pradžia › Nedidelinių ląstelių plaučių vėžys
Nedidelinių ląstelių plaučių vėžys klinikiniai tyrimai JAV ieško dalyvių
429 tyrimai dėl Nedidelinių ląstelių plaučių vėžys ieško dalyvių vietose visoje Jungtinėse Valstijose.
Miestai su daugiausia tyrimų
- Houston, TX145 tyrimai
- New York City, NY120 tyrimai
- Arlington, VA104 tyrimai
- Nashville, TN97 tyrimai
- Boston, MA90 tyrimai
- Los Angeles, CA87 tyrimai
- St. Louis, MO73 tyrimai
- Chicago, IL61 tyrimas
- Baltimore, MD60 tyrimai
- San Antonio, TX59 tyrimai
- Columbus, OH56 tyrimai
- Washington, DC55 tyrimai
- Seattle, WA53 tyrimai
- Dallas, TX52 tyrimai
- Tampa, FL51 tyrimas
- Philadelphia, PA51 tyrimas
- Queens, NY49 tyrimai
- Pittsburgh, PA48 tyrimai
- San Diego, CA48 tyrimai
- Atlanta, GA47 tyrimai
- Edison, NJ47 tyrimai
- Portland, OR46 tyrimai
- Santa Monica, CA45 tyrimai
- Grand Rapids, MI44 tyrimai
- Detroit, MI44 tyrimai
- Orlando, FL44 tyrimai
- Cleveland, OH43 tyrimai
- New Haven, CT41 tyrimas
- Durham, NC39 tyrimai
- Jacksonville, FL39 tyrimai
- Rochester, MN37 tyrimai
- Baldwin Park, CA36 tyrimai
- San Francisco, CA36 tyrimai
- Cincinnati, OH35 tyrimai
- Indianapolis, IN32 tyrimai
- Kansas City, MO31 tyrimas
- Miami, FL31 tyrimas
- Salt Lake City, UT31 tyrimas
- Aurora, CO30 tyrimai
- Austin, TX30 tyrimai
Pagal valstiją
- Aidahas18 tyrimai
- Ajova29 tyrimai
- Alabama36 tyrimai
- Aliaska11 tyrimai
- Arizona66 tyrimai
- Arkansas34 tyrimai
- Delaveras21 tyrimas
- Džordžija73 tyrimai
- Florida155 tyrimai
- Havajai10 tyrimai
- Ilinoisas94 tyrimai
- Indianas49 tyrimai
- Kalifornija207 tyrimai
- Kanzasas34 tyrimai
- Kentukis46 tyrimai
- Koloradas73 tyrimai
- Kolumbijos apskritis38 tyrimai
- Konektikutas55 tyrimai
- Luiziana26 tyrimai
- Masčusetsas102 tyrimai
- Menas16 tyrimai
- Merilendas76 tyrimai
- Minesota69 tyrimai
- Misisipė20 tyrimai
- Misūris86 tyrimai
- Mičiganas101 tyrimas
- Montana18 tyrimai
- Naujoji Hampšyras17 tyrimai
- Nebraska40 tyrimai
- Nevada25 tyrimai
- New Jersey88 tyrimai
- New Mexico22 tyrimai
- New York169 tyrimai
- North Carolina79 tyrimai
- North Dakota15 tyrimai
- Ohio121 tyrimas
- Oklahoma31 tyrimas
- Oregon60 tyrimai
- Pennsylvania103 tyrimai
- Rhode Island13 tyrimai
- South Carolina30 tyrimai
- South Dakota20 tyrimai
- Tennessee118 tyrimai
- Texas204 tyrimai
- Utah56 tyrimai
- Vermont7 tyrimai
- Virginia137 tyrimai
- Washington84 tyrimai
- West Virginia14 tyrimai
- Wisconsin45 tyrimai
Nesenai atnaujinti tyrimai
Oficialus tyrimo tekstas (anglų kalba)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT04267848A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT06623422Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT02146170Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT06472245A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT07293247The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Renkami dalyviai1/2 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT04585750A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT06465069A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT07680764Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT07751042A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
Renkami dalyviai2/3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT07365319A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT06270706Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT06265285Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT05176483Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT06918132A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT06780085A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT07513376A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT06172478177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT07189871A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT07090499Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT07388524A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Renkami dalyviai2/3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT07155187Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT06625775A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT06907615A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT07554339A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT07190248Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.